Therapeutic Potential of Downregulated Interleukin-6 Signaling for the Treatment of Chronic Pain: A Mendelian Randomization Study
Yaodan Bi,1,* Yingchao Zhu,2,* Shuai Tang1 1Department of Anesthesiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 2Department of Anesthesiology, West China Hospital, Sichuan Univ...
Main Authors: | Bi Y, Zhu Y, Tang S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-12-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/therapeutic-potential-of-downregulated-interleukin-6-signaling-for-the-peer-reviewed-fulltext-article-JPR |
Similar Items
-
Causal relationship of interleukin-6 and its receptor on sarcopenia traits using mendelian randomization
by: Baixing Chen, et al.
Published: (2024-05-01) -
Circulating interleukin-27 is associated with the risk of chronic periodontitis and allergic rhinitis: A Mendelian randomization analysis
by: Nan Jiang, et al.
Published: (2024-12-01) -
Mendelian randomization study on causal association of IL-6 signaling with pulmonary arterial hypertension
by: Min Zhang, et al.
Published: (2023-12-01) -
Relationship of Soluble Interleukin-6 Receptors With Asthma: A Mendelian Randomization Study
by: Yoshihiko Raita, et al.
Published: (2021-04-01) -
Assessing the causal relationship between genetically determined inflammatory biomarkers and low back pain risk: a bidirectional two-sample Mendelian randomization study
by: Wenhan Li, et al.
Published: (2023-07-01)